Director Commits 9.99% Stake to Vote for Noble Africa Merger

summarizeSummary

A director of ENDRA Life Sciences Inc. has formally agreed to vote his 9.99% beneficial ownership in favor of the proposed merger with Noble Africa and related corporate actions, including a potential reverse stock split.

check_boxKey Events · Ownership and Investor Activity · NDRA

• Director Voting Agreement

  Anthony DiGiandomenico, a director, entered into a voting agreement on June 25, 2026, committing to vote his shares in favor of the merger with Noble Africa.

• Significant Stake Committed

  The director beneficially owns 196,692 shares, representing 9.99% of the company's outstanding common stock, which he has pledged to support the merger.

• Support for Key Proposals

  The agreement includes voting for the issuance of shares for the merger, a potential reverse stock split to maintain Nasdaq listing, a new equity incentive plan, and an amended certificate of incorporation (renaming the company to "Noble Africa Inc.").

• Irrevocable Proxy Granted

  The director has granted an irrevocable proxy to the company to ensure his votes are cast as required by the agreement.

auto_awesomeAnalysis · NDRA · Industrial Applications And Services

This Schedule 13D/A confirms a key director's support for the recently announced merger with Noble Africa, which is critical for ENDRA Life Sciences' future. Anthony DiGiandomenico, holding nearly 10% of the company's shares, has entered into a voting agreement and granted an irrevocable proxy to ensure his vote for the merger, a potential reverse stock split, and other necessary corporate governance changes. This commitment reduces uncertainty regarding shareholder approval for the transformational transaction.